2010
DOI: 10.1097/nen.0b013e3181eaeae5
|View full text |Cite
|
Sign up to set email alerts
|

Expression of the Interleukin 6 System in Cortical Lesions From Patients With Tuberous Sclerosis Complex and Focal Cortical Dysplasia Type IIb

Abstract: Tuberous sclerosis complex (TSC) and focal cortical dysplasia type IIb (FCDIIb) are characterized by epilepsy-associated cerebral cortical malformations. To understand the potential role of the inflammatory cytokine interleukin 6 (IL-6) in the pathogenesis of these lesions, we analyzed the IL-6 system in TSC and FCDIIb cortical lesions and in control cortex (CTX). Greater messenger RNA and protein levels of IL-6 and of its receptors (i.e. IL-6 receptor [IL-6R] and glycoprotein 130 [gp130]) were observed in TSC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
28
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 41 publications
(32 citation statements)
references
References 39 publications
3
28
0
1
Order By: Relevance
“…It is that the persistent neuronal upregulation of TRPC5 in BCs of human FCD tissue influence the neurite growth and then disrupt the normal neuronal circuitry, and finally contribute to epileptogenesis. In addition, consistent with the previous studies (He et al 2013;Shu et al 2010;Oh et al 2008), immunohistochemistry analyses showed that BCs labeled with both the neuronal marker NeuN and glial marker GFAP, suggesting that they could be both neuronal and glial lineages. Oh et al suggested that the BCs are incompletely matured cells of glial or neuronal lineage and that they are formed by the abnormal morphologic differentiation of neural stem cells during early neural development (Oh et al 2008).…”
Section: Discussionsupporting
confidence: 85%
“…It is that the persistent neuronal upregulation of TRPC5 in BCs of human FCD tissue influence the neurite growth and then disrupt the normal neuronal circuitry, and finally contribute to epileptogenesis. In addition, consistent with the previous studies (He et al 2013;Shu et al 2010;Oh et al 2008), immunohistochemistry analyses showed that BCs labeled with both the neuronal marker NeuN and glial marker GFAP, suggesting that they could be both neuronal and glial lineages. Oh et al suggested that the BCs are incompletely matured cells of glial or neuronal lineage and that they are formed by the abnormal morphologic differentiation of neural stem cells during early neural development (Oh et al 2008).…”
Section: Discussionsupporting
confidence: 85%
“…Total RNA samples (n = 8 each subunit) were isolated from the hippocampus and temporal cortex using an RNA extraction method that has been previously described [6]. The quality and quantity of the final RNA were determined with a NanoDrop 2000 Spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and were verified by agarose gel electrophoresis.…”
Section: Rna Isolation and Rt-pcrmentioning
confidence: 99%
“…As in our previous report [6], protein extraction from the hippocampus and temporal cortex was performed according to the manufacturer's protocol (Biyuntian Technologic Inc., China). Tissue homogenates were lysed in RIPA buffer containing 1 9 phosphate-buffered saline (PBS), 1 % IGEPAL CA-630, 0.5 % sodium deoxycholate, 0.1 % sodium dodecyl sulfate, and 10 % protease inhibitor cocktail (Sigma, St Louis, MO, USA).…”
Section: Western Blottingmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, we aimed to determine if the changes in cytokine levels could predict the clinical response. Therefore, we determined levels of interleukin (IL)-1β and IL-6, while these cytokines were increased in epilepsy patients [21,22,23,24,25,26]. Additionally, we also evaluated levels of IL-10, as this is one of the most important anti-inflammatory cytokines [27].…”
Section: Introductionmentioning
confidence: 99%